Total Payments
$13,664
2024 Payments
$135.58
Companies
19
Transactions
88
Medicare Patients
1,641
Medicare Billing
$185,536
Payment Breakdown by Category
Other$8,467 (62.0%)
Travel$2,728 (20.0%)
Food & Beverage$2,263 (16.6%)
Consulting$200.00 (1.5%)
Education$5.46 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $8,467 | 8 | 62.0% |
| Travel and Lodging | $2,728 | 5 | 20.0% |
| Food and Beverage | $2,263 | 70 | 16.6% |
| Consulting Fee | $200.00 | 1 | 1.5% |
| Education | $5.46 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aries Pharmaceuticals, Inc. | $10,778 | 18 | $0 (2018) |
| Covidien LP | $981.12 | 5 | $0 (2018) |
| Boston Scientific Corporation | $666.67 | 11 | $0 (2024) |
| PFIZER INC. | $225.54 | 6 | $0 (2024) |
| Ethicon Inc. | $171.35 | 1 | $0 (2017) |
| AbbVie, Inc. | $146.31 | 10 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $123.24 | 10 | $0 (2020) |
| Ethicon US, LLC | $117.41 | 3 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $116.16 | 2 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $73.09 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.58 | 2 | Boston Scientific Corporation ($118.67) |
| 2023 | $172.50 | 3 | Boston Scientific Corporation ($172.50) |
| 2022 | $55.82 | 1 | Boston Scientific Corporation ($55.82) |
| 2021 | $141.15 | 3 | BOSTON SCIENTIFIC CORPORATION ($127.55) |
| 2020 | $81.71 | 5 | PFIZER INC. ($31.39) |
| 2019 | $412.27 | 18 | PFIZER INC. ($177.24) |
| 2018 | $7,972 | 30 | Aries Pharmaceuticals, Inc. ($6,628) |
| 2017 | $4,692 | 26 | Aries Pharmaceuticals, Inc. ($4,150) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/26/2024 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $118.67 | General |
| Category: SpyGlass_ENDO | ||||||
| 12/11/2023 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $48.13 | General |
| Category: SpyGlass_ENDO | ||||||
| 10/20/2023 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $90.22 | General |
| Category: SpyGlass_ENDO | ||||||
| 03/30/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: EXALT_ENDO | ||||||
| 07/19/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $55.82 | General |
| Category: EXALT_ENDO | ||||||
| 11/03/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | Cash or cash equivalent | $49.74 | General |
| Category: EXALT | ||||||
| 08/05/2021 | Medtronic, Inc. | SharkCore (Device) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Endoscopic Ultrasound | ||||||
| 07/27/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | In-kind items and services | $77.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/03/2020 | Alfasigma USA, Inc. | — | Food and Beverage | In-kind items and services | $22.25 | General |
| 02/11/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/03/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Immunology | ||||||
| 01/28/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/07/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Immunology | ||||||
| 10/31/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | APRISO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/27/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $12.09 | General |
| 10/08/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Immunology | ||||||
| 10/01/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Lower GI | ||||||
| 09/11/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Viberzi | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Gastroenterology | ||||||
| 08/27/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 07/30/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 283 | 318 | $174,582 | $31,796 |
| 2022 | 14 | 412 | 439 | $287,062 | $45,440 |
| 2021 | 17 | 484 | 539 | $320,651 | $55,253 |
| 2020 | 16 | 462 | 501 | $282,744 | $53,047 |
Total Patients
1,641
Total Services
1,797
Medicare Billing
$185,536
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 68 | $16,252 | $6,058 | 37.3% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 14 | 19 | $26,220 | $5,406 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,625 | $3,280 | 28.2% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $14,050 | $3,143 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $19,383 | $2,879 | 14.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 18 | 18 | $16,614 | $2,284 | 13.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $7,406 | $2,101 | 28.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $21,920 | $1,952 | 8.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 24 | $4,128 | $1,460 | 35.4% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 15 | 23 | $25,139 | $1,455 | 5.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $9,843 | $1,390 | 14.1% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 14 | 22 | $2,002 | $388.96 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 73 | $17,447 | $6,161 | 35.3% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 12 | 18 | $24,840 | $4,498 | 18.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $39,689 | $4,467 | 11.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 35 | 35 | $32,305 | $4,153 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $15,375 | $3,861 | 25.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 21 | $22,029 | $3,677 | 16.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 26 | $8,372 | $2,593 | 31.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 41 | 41 | $27,721 | $2,551 | 9.2% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 16 | $14,000 | $2,536 | 18.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,488 | $2,306 | 30.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $12,648 | $2,303 | 18.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 11 | 11 | $11,539 | $2,093 | 18.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 15 | 15 | $10,205 | $1,129 | 11.1% |
About Dr. Sheetal Sharma, M.D
Dr. Sheetal Sharma, M.D is a Gastroenterology healthcare provider based in Washington, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538328885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheetal Sharma, M.D has received a total of $13,664 in payments from pharmaceutical and medical device companies, with $135.58 received in 2024. These payments were reported across 88 transactions from 19 companies. The most common payment nature is "Honoraria" ($8,467).
As a Medicare-enrolled provider, Sharma has provided services to 1,641 Medicare beneficiaries, totaling 1,797 services with total Medicare billing of $185,536. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Washington, MO
- Active Since 06/03/2008
- Last Updated 05/27/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1538328885
Products in Payments
- ELEVIEW (Device) $10,778
- Barrx (Device) $436.42
- LINX Reflux Management System (Device) $288.76
- SpyGlass (Device) $257.02
- XELJANZ (Drug) $225.54
- Entyvio (Biological) $131.83
- EXALT (Device) $127.55
- UCERIS (Drug) $95.79
- Humira (Biological) $93.15
- EXALT Model D (Device) $89.97
- GENERAL BILIARY DEVICES (Device) $81.03
- PillCam (Device) $80.99
- AXIOS (Device) $58.60
- SPYGLASS DIRECT VISUALIZATION SYSTEM (Device) $52.50
- STELARA (Biological) $48.33
- Creon (Drug) $41.07
- Trulance (Drug) $37.18
- Mulpleta (Drug) $31.14
- LINZESS (Drug) $27.88
- SUPREP (Drug) $25.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Washington
James Lewis
Gastroenterology — Payments: $1.2M
Gastroenterology $1.2M
Dr. John Hogan, M.d, M.D
Gastroenterology — Payments: $533,987
Gastroenterology $533,987
Dr. Mark Mattar, Md, MD
Gastroenterology — Payments: $385,054
Gastroenterology $385,054
Jessica Korman, M.d, M.D
Gastroenterology — Payments: $114,919
Gastroenterology $114,919
Dr. Roshan Bashir, M.d, M.D
Gastroenterology — Payments: $61,004
Gastroenterology $61,004
Dr. Dominique Howard, M.d, M.D
Gastroenterology — Payments: $27,909
Gastroenterology $27,909